-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5

Benzinga·09/16/2026 13:10:41
Listen to the news
UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.